Page last updated: 2024-11-13

tro 40303

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,5-seco-4-norcholestan-5-one oxime-3-ol: a cardioprotective agent; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID117902620
CHEMBL ID4297500
SCHEMBL ID16506095
MeSH IDM0547112

Synonyms (12)

Synonym
SCHEMBL16506095
tro-40303
7h-benz(e)inden-7-one, 3-((1r)-1,5-dimethylhexyl)dodecahydro-6-(3-hydroxypropyl)-3a,6-dimethyl-, oxime, (3r,3ar,5as,6r,9as,9bs)-
3W389841RN ,
(3r,3ar,5as,6r,9as,9bs)-3-((1r)-1,5-dimethylhexyl)-6-(3-hydroxypropyl)-3a,6-dimethyl-1,2,3,4,5,5a,8,9,9a,9b-decahydrocyclopenta(a)naphthalen-7-one oxime
3,5-seco-4-norcholestan-5-one oxime-3-ol
14291-24-8
tro 40303
tro40303
unii-3w389841rn
CHEMBL4297500
EX-A3773

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" There were no serious adverse events reported."( Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial.
Abitbol, JL; Afxantidis, J; Berdeaux, A; Berna, P; Chaimbault, C; Culcasi, M; Donazzolo, Y; Latreille, M; Le Lamer, S; Michaud, M; Morin, D; Paradis, S; Pietri, S; Pruss, RM; Rahmouni, H; Schaller, S, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's13 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.90 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index5.84 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (28.57%)5.53%
Reviews2 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (57.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]